Immune Checkpoint Inhibitor–Associated Autoimmune Bullous Diseases: Beyond Bullous Pemphigoid
International Journal of Dermatology · 2026-07 · 65 (7) · 1357-1358
DOI: 10.1111/ijd.70408 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Dermatology, online erschienen am 25.03.2026. Verfasst von Ioannis-Alexios Koumprentziotis und 1 weiteren Autor:innen. Beteiligte Einrichtung: 1st Department of Dermatology and Venereology, Medical School, National and Kapodistrian University of Athens, 'A. Sygros' Hospital for Skin and Vene…. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- 1st Department of Dermatology and Venereology, Medical School, National and Kapodistrian University of Athens, 'A. Sygros' Hospital for Skin and Venereal Diseases, Athens, Greece.
ORCID-Profile: Ioannis-Alexios Koumprentziotis, Vasiliki Nikolaou
Zitieren
APA
Koumprentziotis, I. A., & Nikolaou, V. (2026). Immune Checkpoint Inhibitor–Associated Autoimmune Bullous Diseases: Beyond Bullous Pemphigoid. International Journal of Dermatology, 65(7), 1357-1358. https://doi.org/10.1111/ijd.70408
Vancouver
Koumprentziotis IA, Nikolaou V. Immune Checkpoint Inhibitor–Associated Autoimmune Bullous Diseases: Beyond Bullous Pemphigoid. International Journal of Dermatology. 2026;65(7):1357-1358. doi:10.1111/ijd.70408
BibTeX
@article{Koumprentziotis2026,
author = {Koumprentziotis, Ioannis-Alexios and Nikolaou, Vasiliki},
title = {Immune Checkpoint Inhibitor–Associated Autoimmune Bullous Diseases: Beyond Bullous Pemphigoid},
journal = {International Journal of Dermatology},
year = {2026},
volume = {65},
number = {7},
pages = {1357--1358},
doi = {10.1111/ijd.70408}
}
EUVIMED